Glatiramer acetate enhances tumor retention and innate activation of immunostimulants
Melissa M. Pressnall, Aric Huang, Chad E. Groer, Sebastian G. Huayamares, M. Laird Forrest, Cory Berkland
Topics & Concepts
ImmunostimulantImmune systemProinflammatory cytokineImmunotherapyTLR9CytokineImmunologyInnate immune systemTumor microenvironmentTLR3Glatiramer acetateCpG OligodeoxynucleotideCpG siteCancer researchImmunosurveillanceChemistryPharmacologyInflammationMedicineToll-like receptorMultiple sclerosisBiochemistryGene expressionDNA methylationGeneImmunotherapy and Immune ResponsesImmune Response and InflammationRNA Interference and Gene Delivery